@hboy - Protestors probably being paid by China.
Either way i think your comments are a pretty simplistic take on a company with many different factors in play that can materially affect its valuation.
While natural graphite prices have been brutaally subdued (along with nearly all battery metals where China dominates and controls the market) - we need Balama running if we are to take advantage of strong Coarse flake prices, be a reliable ex-China supplier, to meet our DOE loan requirements and to be able to supply Vidalia with feedstock (which following all the pre-qualificatoon works quietly going on this past 12+ months could fire up very quickly indeed to commercial production) at anytime given the US is finally getting serious about building out its own manufacturing capacity (including EV supply chain and critical minerals). Not to mention the US hearings into China's graphite and AAM subsidies and dumping which could turbo charge things for Syrah.
And your comments show very little appreciation of what Vidalia would cost to build and is capable of if US industry is protected from unfair predatory pricing and US OEMs forced to support local, let alone the value of a Tier 1 resource like Balama and the strategic value of the AAM know-how and experience they have built up in a rapidly fracturing global trade environment. The value of the above far exceeds the current share price by many multiples, should even a couple other pieces fall into place which looks increasingly likely - more than a anytime in the past 18+ months.
- Forums
- ASX - By Stock
- Ann: Balama site access restored
SYR
syrah resources limited
Add to My Watchlist
1.96%
!
26.0¢

@hboy - Protestors probably being paid by China.Either way i...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
26.0¢ |
Change
0.005(1.96%) |
Mkt cap ! $270.9M |
Open | High | Low | Value | Volume |
25.5¢ | 27.3¢ | 25.5¢ | $634.3K | 2.391M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 379430 | 26.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.5¢ | 40672 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 379430 | 0.260 |
9 | 238069 | 0.255 |
16 | 483863 | 0.250 |
13 | 503263 | 0.245 |
22 | 860417 | 0.240 |
Price($) | Vol. | No. |
---|---|---|
0.265 | 40672 | 5 |
0.270 | 144245 | 2 |
0.275 | 628178 | 11 |
0.280 | 177739 | 6 |
0.285 | 418600 | 6 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
SYR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online